|
⚲
|
| Keyboard |
| Mossler Mark
✚
|
|
|---|---|
| CIK # | 0001992219 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001992219] | |
| 4 | [0001992219] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| C4 Therapeutics Inc | |
| Mossler Mark |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Option exercise | 9,420 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-14 | Tax withheld | 3,268 | $1.89 | 6,177 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2026-02-13 | Grant | 56,980 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2025-02-14 | Tax withheld | 1,586 | $3.18 | 5,043 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2024-02-14 | Grant | 18,290 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2024-02-14 | Grant | 27,430 | $0.00 |